Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Vitreoretinal Diseases and Surgery
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
Answer from: at Community Practice
You can do systemic clindamycin if not macula-involving. You can also do intravitreal clindamycin if it is macula-involving.
Sign in or Register to read more
26876
Related Questions
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
How do you approach patient selection for starting intravitreal complement inhibitors?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
How should diabetic retinopathy surveillance be adjusted for patients starting GLP-1 agonists?
How do you typically manage the use of intravitreal antibiotics during globe repair?
How do you approach the management of a patient with a small, indeterminate choroidal mass with no obvious primary malignancy?
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
When should amblyopia treatment be initiated in patients being treated for retinoblastoma?
When should methotrexate injections be initiated for proliferative vitreoretinopathy?
In which settings would you use external beam radiotherapy for retinoblastoma in the upfront (new diagnosis) setting?